Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Cell Therapeutics completes enrollment for pixantrone phase III EXTEND trial in NHL

March 26, 2008

Seattle Genetics begins phase I trial of SGN-33 plus Revlimid in MDS patients

March 26, 2008

Mifamurtide now available through compassionate access study

March 25, 2008

Genzyme withdraws EU application to extend Evoltra and plans to resubmit

March 25, 2008

New compounds for the treatment of cancer disclosed in recent patent literature

March 25, 2008

BioNumerik and ASKA present results from phase III Tavocept trial

March 20, 2008

Cytopia selects JAK2 clinical candidate for myeloproliferative disorders

March 20, 2008

PhytoMedical to initiate third phase of drug development program for novel anticancer compounds

March 20, 2008

FDA does not grant approval for Genta's Genasense in chronic lymphocytic leukemia

March 19, 2008

BioCancell initiates treatment in phase IIb clinical trial of BC-819 for superficial bladder cancer

March 19, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...